Viread Related Clinical Trials
A 96 Week Study to Compare Tenofovir Versus Tenofovir Plus Emtricitabine for the Treatment of Chronic Hepatitis B [Active, not recruiting]
Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers [Completed]
Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, & Entecavir in the Treatment of Chronic HBV in Subjects w/Decompensated Liver Disease. [Active, not recruiting]
A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of HBeAg Negative Chronic Hepatitis B [Active, not recruiting]
A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B [Active, not recruiting]
Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir [Completed]
Tenofovir Disoproxil Fumarate (DF) Versus Emtricitabine/Tenofovir DF Fixed-Dose in Subjects Resistant to Lamivudine [Recruiting]
Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women [Not yet recruiting]
Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia [Terminated]
Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV [Active, not recruiting]
Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients [Terminated]
Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil [Active, not recruiting]
Study of Treatment of Antiretroviral-Naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz. [Active, not recruiting]
Testing the Safety of Tenofovir Vaginal Gel in Pregnant Women Who Are Having a C-Section
Kaletra and Viread in Antiretroviral Naïve Patients [Recruiting]
Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients [Completed]
Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV [Recruiting]
A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection [Recruiting]
Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants [Active, not recruiting]
Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients [Terminated]
A Single-Arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without Add-on Tenofovir in Adults With HBeAg-Positive Chronic Hepatitis B (CHB) [Recruiting]
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children (Ages 2- <12) [Active, not recruiting]
A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes, and Eliminates a Drug), of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Nave HIV-1 Patients (Patients Have Never Received ARV Treatment). [Active, not recruiting]
Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir DF in HIV-1-Infected Treatment Naive Adults [Active, not recruiting]
Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B [Recruiting]
Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC [Completed]
Bone Mineral Density Substudy - An Ancillary Study to MTN-003 [Not yet recruiting]
Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B Infection [Recruiting]
Botswana Tenofovir Oral HIV Prophylaxis Trial [Terminated]
Tenofovir Disoproxil Fumarate to Treat Pediatric HIV [Completed]
Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects [Active, not recruiting]
Tenofovir Disoproxil Fumarate (DF)/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects [Active, not recruiting]
Bangkok Tenofovir Study [Recruiting]
Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients [Completed]
A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection [Completed]
The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients [Active, not recruiting]
Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery [Not yet recruiting]
Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection [Completed]
Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-Infected Patients With Tuberculosis [Not yet recruiting]
Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples [Recruiting]
A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine [Active, not recruiting]
Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV [Terminated]
Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women [Not yet recruiting]
The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients [Active, not recruiting]
A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV [Completed]
Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA) [Recruiting]
Efficacy and Tolerance of Peg-Interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV co-Infected Patients [Recruiting]
Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women [Not yet recruiting]
Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV co-Infected Patients [Recruiting]
Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug Combinations [Active, not recruiting]
Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection [Not yet recruiting]
Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects [Completed]
FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment [Completed]
Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel [Completed]
Effect of Tenofovir DF on Bone Metabolism in Children [Completed]
Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs
Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men
Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV
Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy
Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART. [Completed]
Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir [Recruiting]
Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies [Recruiting]
GSK1349572 Drug Interaction With Tenofovir [Not yet recruiting]
ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens [Not yet recruiting]
A Dose Escalation Study of GS-7340-02 in Treatment Naive Patients [Completed]
A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects [Withdrawn]
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection [Recruiting]
A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection [Recruiting]
Truvada Versus Truvada Plus HBIG in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant [Recruiting]
Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF) [Not yet recruiting]
Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-Infected Patients [Not yet recruiting]
Once-Daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl [Recruiting]
Safety and Acceptability of a Vaginal Microbicide [No longer recruiting]
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL) [Recruiting]
Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients [Recruiting]
Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA) [Recruiting]
Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B [Recruiting]
Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects [Recruiting]
Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada [Recruiting]
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults [Active, not recruiting]
A Randomised, Open-Label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-Emtricitabine or Abacavir-Lamivudine: The STEAL Study [Recruiting]
Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV [Active, not recruiting]
Tenofovir in HIV/HBV Coinfection [No longer recruiting]
Preventing Sexual Transmission of HIV With Anti-HIV Drugs [Recruiting]
Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults [Not yet recruiting]
Botswana TDF/FTC Oral HIV Prophylaxis Trial [Recruiting]
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men [Recruiting]
Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy [Completed]
Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients [Completed]
Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207) [Completed]
To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir. [Completed]
Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People [Completed]
A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients [Recruiting]
Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism [Recruiting]
A Comparison of Two Drug Combinations Used in HIV-Infected Patients Who Never Have Taken Anti-HIV Drugs [Completed]
Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis [Recruiting]
Effectiveness of Nucleoside Supplementation and Substituting Tenofovir Disoproxil Fumarate for Other Drugs in Anti-HIV Regimens in Reversing Fat Loss in HIV Infected Adults [Recruiting]
A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy [No longer recruiting]
Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure [Completed]
Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients [Completed]
New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects [Completed]
|
